| Inclusion criteria | Exclusion criteria |
---|---|---|
Participants | Infants ≥ 34 + 0 weeks GA Diagnosis of NE GMA done between birth up to 6 months of life Assessment for CP by at least 2 years of age | Infants born with: - Life threatening congenital abnormalities - Congenital viral infections - An abnormal karyotype and - Metabolic disorders |
Concept | GMA as a predictor of CP by 2 years of age is the main concept. | Â |
Context | Studies that reported on the following: -Infants with NE managed in hospitals and diagnosed by the standard of care (neurological history and examination) -Studies from all countries that have outcomes reported in the acute neonatal and in the follow-up period by 2 years of age -Studies in the English language only | Â |